This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
 
Cramer Answers Twitter Questions on Netflix, Home Depot, FireEye

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Lincoln Starts Sales in China, Watch For More Matthew McConaughey

Lincoln's Matt VanDyke says there's a lot of interest from Chinese customers as the automaker opens its first three showrooms in China this month.

Apple Poised to Win the Battle of Black Friday Sales Supremacy

The battle for Black Friday sales supremacy is heating up.

Stocks Start Thanksgiving Week Higher, Holiday Sales Predictions

U.S. markets started this shortened trading week higher.

Warren Buffett's Drywall Play Bets on USG Paying off on Construction

USG Corp. has burned Warren Buffett before -- the Oracle of Omaha ate it in 2000, after his bet on the drywall materials company went sour.

Real Money Previews

Jim Cramer on the Markets: Remember Investors, We're Not China

Here's why Cramer's not crazy about Caterpillar or Cummins.

Upbeat on Bon-Ton and Energy; Short Consumer Staples: Best of Kass

In highlights from his trading diary of the past week, Doug Kass discusses why he's net-short amid slowing global growth, with some bright spots being Bon-Ton and the energy sector.

PPG Is Spot-On; The Hazards of Skepticism: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about PPG's Mexico deal and the market's amazing run.

Mad Money Recap

'Mad Money' Lightning Round: I'll Take Popeyes Over Wendy's

Cramer can't recommend Dynavax Technologies but wants you to hold Noble Energy.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Rocket Stocks for Gluttonous Turkey Day Gains: Boeing and More

Thanksgiving week has a distinct bullish bias for the stock market.

Time to Sell These 5 'Toxic' Stocks: Bitauto Holdings and More

For investors looking to buy one of these positions, it makes sense to wait for more favorable technical conditions (and a lower share price) before piling in.

5 Earnings Short-Squeeze Plays: Workday, Trina Solar and More

You only need to find a few short-squeeze plays to juice your annual returns.

Must-See Charts: How to Trade IBM, Applied Materials and More

Skilled technical traders can bank gains as much as 90% of the time.

5 Stocks With Big Insider Trading: Groupon, Jive Software and More

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

MainStreet

Half of Americans Wished They’d Started Retirement Savings Sooner

As usual with surveys on Americans and their savings, there's a disconnect in what savers say they need to accomplish and what they actually accomplish.

Mayor of Amsterdam To Cannabis Cup: You Are Not In Compliance

First day's Expo of famed Cannabis Cup Amsterdam cancelled after organizers work behind scenes to meet new regulatory requirements.

Why Real Estate Agents Need a Web and Mobile Tracking App

Some 50% of real estate professionals use a shoebox as their primary expense tracking tool.

3 Items for Your 2014 Year-End Retirement Planning Checklist

Thinking about New Year's resolutions? Don't forget your retirement planning checklist.

A Professional’s Guide To Medical & Recreational Use In Amsterdam

A not too tongue in cheek review of local pot laws and regulations circa November 2014 as Amsterdam prepares for Cannabis Cup.

Biotech

Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing

The scandal-ridden Galena, still under active SEC investigation, was unable to muster sufficient interest from institutional investors.

BioMarin Expands Reach By Buying Prosensa for Up to $840 Million

BioMarin is betting that its experience in securing approvals for "orphan-disease" drugs can help Prosensa win approval for drisapersen, an experimental treatment for Duchenne muscular dystrophy.

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Beyond Wall St.

Deal News

It's a Nightmare Before Christmas for These Zombie Retailers

Once upon a time, struggling retailers could hold out until after the holidays before deciding whether to file for bankruptcy.

RenaissanceRe Rolls Up Platinum Underwriters for $1.9 Billion

Bermuda-based insurers combine in cash and stock deal.

Joe's Jeans Fades with Market Demand and Looks for Deal with Lenders

The denim apparel maker is in default on its debt for failing to comply with the Ebitda covenant on its term loan.

TheStreetTV
Spin Space

Jim Cramer

Cramer Answers Twitter Questions on Netflix, Home Depot, FireEye

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Herb Greenberg

Greenberg: How Hertz Fooled So Many Hedge Fund Managers

But suing Audit Integrity wasn't such a good idea.

Stephanie Link

Dicker/Link: Tubular Bells Offshore Project Begins Production - but No Reason Yet to Invest

Dan Dicker talks with Stephanie Link, co-portfolio director of Action Alerts, about the beginnings of production of a $2.3 billion offshore project co-owned by Hess and Chevron.

Chris Ciaccia

How Apple Is Absolutely Poised to Win Black Friday 2014

With perhaps the strongest product lineup ever, Apple is poised to win Black Friday and perhaps the entire holiday season like never before.

Adam Feuerstein

Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing

The scandal-ridden Galena, still under active SEC investigation, was unable to muster sufficient interest from institutional investors.

Dan Freed

Are Google, Facebook and Alibaba More Dangerous Than the NSA?

The question isn’t easy to answer, says first amendment scholar and University of Chicago Professor Geoffrey Stone.

Ted Reed

A Small Step in American/US Air Merger Becomes Something More

American and US Airways ticket counters in Charlotte moved closer together on Friday, and employees made that into something more.

Leon Lazaroff

Aereo May Be Dead, But Over-The-Top Television Is Just Beginning

Aereo's bankruptcy brings to an end a company that filled the public's demand for choice and mobility. Another provider would be wise to acquire its technology.

Submit an article to us!
DOW 17,811.96 +1.90 0.01%
S&P 500 2,066.97 +3.47 0.17%
NASDAQ 4,738.3590 +25.3890 0.54%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs